Share on LinkedInShare on LinkedIn

ARTICLE · 06 JUNE 2012

Certification Of Action Against Drug Manufacturers Denied

Blake, Cassels & Graydon LLP
Blake, Cassels & Graydon LLP
Contributor
Blake, Cassels & Graydon LLP

Blake, Cassels & Graydon LLP

As one of Canada’s top business law firms, Blake, Cassels & Graydon LLP (Blakes) provides...

View firm profile
Explore more from Blake, Cassels & Graydon LLP

On April 19, 2012, the Québec Court of Appeal (the Court) rendered the first decision on misleading advertising since the ruling of the Supreme Court of Canada (the SCC) in Richard v. Time Inc. In Perreault v. McNeil PDI Inc.,

CanadaLitigation, Mediation & Arbitration

Overview

On April 19, 2012, the Québec Court of Appeal (the Court) rendered the first decision on misleading advertising since the ruling of the Supreme Court of Canada (the SCC) in Richard v. Time Inc. In Perreault v. McNeil PDI Inc., the Court clarified the rules for awarding punitive damages in consumer law and reiterated that an applicant seeking authorization to institute a class action must prove a personal cause of action.

Procedural Context

On October 12, 2007, the appellant applied for authorization to institute a class action against various manufacturers of drugs for the relief of cold and cough symptoms in children.

The appellant had administered such drugs to her young children and stated that she never noticed any adverse side effects. However, the action is based on what she describes as the possibility that such products might be harmful.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from